Voxvoganan
Voxvoganan (LTX-109, Lytixar) is an experimental antibiotic medication for topical use.
Snapshot
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Voxvoganan (LTX-109, Lytixar) is an experimental antibiotic medication for topical use. It is a synthetic peptide which is in clinical trials against skin infections caused by drug-resistant strains of Staphylococcus aureus.
Text derived from https://en.wikipedia.org/w/index.php?oldid=1330640384 under CC BY-SA 4.0; modifications have been made.